Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents

被引:24
作者
Johnson, AP [1 ]
Henwood, C [1 ]
Mushtaq, S [1 ]
James, D [1 ]
Warner, M [1 ]
Livermore, DM [1 ]
机构
[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
关键词
intensive care units; Gram-positive bacteria; antibiotic susceptibility;
D O I
10.1016/S0195-6701(03)00145-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Microbiologists in 25 sentinel laboratories were each asked to refer up to 100 clinically-significant Gram-positive bacteria isolated from consecutive intensive care unit (ICU) patients. A total of 1595 isolates were collected from patients in 23 hospitals; these included Staphylococcus aureus (47.6%), coagulase- negative staphylococci (CNS) (30.6%), enterococci (14.3%), pneumococci (2.8%) and other streptococci (3.5%). A few coryneforms, other bacilli and a Nocardia sp. were atso collected. Rates of oxacillin resistance among S. aureus and CNS isolates were 59.3 and 78.5%, respectively. Vancomycin-resistant S. aureus were not detected, although two isolates (0.3%) were resistant to teicoplanin [minimum inhibitory concentrations (MICs) 8 mg/L]. In contrast, 13.7% of CNS were teicoplanin resistant (MICs 8-32 mg/L) and 1.2% were resistant to vancomycin. Among the enterococci, 72.5% were Enterococcus faecalis and 24.5% were Enterococcus faecium, the remainder including isolates of Enterococcus casseliflavus or Enterococcus gallinarum. Eighteen percent of E. faecium isolates were vancomycin-resistant, compared with only 3% of E. faecalis isotates. Rates of high-level gentamicin resistance in E. faecalis and E. faecium were 40 and 25%, respectively. Nine percent of pneumococci and streptococci were resistant to penicillin, with 7 and 11%, respectively, resistant to erythromycin. None of the isolates showed resistance to linezotid, with the MICs for the entire study population failing in the range of 0.5-4 mg/L. (C) 2003 The Hospital Infection Society. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:179 / 187
页数:9
相关论文
共 22 条
[1]   BSAC standardized disc susceptibility testing method [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :43-57
[2]   A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics [J].
Aucken, HM ;
Ganner, M ;
Murchan, S ;
Cookson, BD ;
Johnson, AP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (02) :171-175
[3]   Linezolid-resistant enterococci: report of the first isolates in the United Kingdom [J].
Auckland, C ;
Teare, L ;
Cooke, F ;
Kaufmann, ME ;
Warner, M ;
Jones, G ;
Bamford, K ;
Ayles, H ;
Johnson, AP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) :743-746
[4]   HIGH-RISK OF HOSPITAL-ACQUIRED INFECTION IN THE ICU PATIENT [J].
DONOWITZ, LG ;
WENZEL, RP ;
HOYT, JW .
CRITICAL CARE MEDICINE, 1982, 10 (06) :355-357
[5]  
DUKTAMALEN S, 1995, J CLIN MICROBIOL, V33, P1434
[6]   Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection [J].
Elsaghier, AAF ;
Aucken, HM ;
Hamilton-Miller, JM ;
Shaw, S ;
Kibbler, CC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (02) :423-424
[7]   Reduced susceptibility to teicoplanin in a methicillin-resistant strain of Staphylococcus aureus [J].
Fitch, L ;
Johnson, AP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) :578-578
[8]   Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2 [J].
Fridkin, SK ;
Steward, CD ;
Edwards, JR ;
Pryor, ER ;
McGowan, JE ;
Archibald, LK ;
Gaynes, RP ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :245-252
[9]   Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid [J].
Gonzales, RD ;
Schreckenberger, PC ;
Graham, MB ;
Kelkar, S ;
DenBesten, K ;
Quinn, JP .
LANCET, 2001, 357 (9263) :1179-1179
[10]   Clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to teicoplanin in Northwest England [J].
Hassan, IA ;
Chadwick, PR ;
Johnson, AP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (03) :454-455